We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardioprotective Effect of 2-Ethyl-3-Hydroxy-6-Methylpyridinium 2-Nitroxysuccinate Against Adrenaline/Hydrocortisone-Induced Myocardial Ischemia in Mice: Modulation of Free-Radical Processes in Biomembranes and Monoamine Oxidase A Activity.
- Authors
Faingold, Irina I.; Smolina, Anastasia V.; Soldatova, Yulia V.; Poletaeva, Darya A.; Balakina, Anastasia A.; Sashenkova, Tatyana E.; Allayarova, Uguljan Yu.; Prikhodchenko, Tatyana R.; Blokhina, Svetlana V.; Makartseva, Lyudmila A.; Areshidze, David A.; Varfolomeev, Vladislav N.; Mishchenko, Denis V.; Kotelnikova, Raisa A.
- Abstract
Oxidative stress (OS) plays a key role in the development of cardiovascular diseases (CVD) in three major ways: reactive oxygen species (ROS)-induced reduction of nitric oxide (NO) bioavailability, ROS-induced inflammation and ROS-induced mitochondrial dysfunction. Oxidation of lipid molecules under the action of ROS leads to damage to membrane structures, changes the functioning of membrane-bound enzymes, and impairs membrane permeability and stability. An increase in OS results in the occurrence of endothelial dysfunction and drug tolerance, side effects, requiring discontinuation of drugs. All of these are significant problems of cardiotherapy. Therefore, the search for new alternative NO donors continues. The present research was aimed at studying the protective effect of 2-ethyl-3-hydroxy-6-methylpyridinium 2-nitroxysuccinate (NS) on the cardiovascular system on mouse myocardial ischemia (MI) model. The NS hybrid molecule includes a synthetic vitamin B6 analog 2-ethyl-3-hydroxy-6-methylpyridine (an antioxidant) and 2-nitroxysuccinic acid (a source of nitric oxide). Using the electron paramagnetic resonance (EPR) method and biochemical methods, we showed that the pronounced ability of NS to release NO is favorably combines with the capacity to prevent OS due to mechanisms such as suppression of the lipid peroxidation (LPO) process, antiradical activity and inhibition of the mitochondrial membrane-bound monoamine oxidase A (MAO-A). Using histological methods, we established that the administration of NS (10 mg/kg, i.p.) reduces the number of ischemic fibers and protects cardiomyocytes against ischemia injury. Thus, the complex protective effect allows us to consider NS as an alternative NO donor and a candidate for the development of a new pharmaceutical agent for the treatment of CVD.
- Subjects
MONOAMINE oxidase; MYOCARDIAL ischemia; MITOCHONDRIAL membranes; ELECTRON paramagnetic resonance; BIOLOGICAL membranes; CARDIOVASCULAR system; CARDIOVASCULAR development
- Publication
Cell Biochemistry & Biophysics, 2024, Vol 82, Issue 1, p235
- ISSN
1085-9195
- Publication type
Article
- DOI
10.1007/s12013-023-01203-7